BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18991198)

  • 1. Wilson's disease: appreciable improvement of sub-cortical white matter abnormalities after copper chelating treatment: five years follow-up.
    Larnaout A; Ammar N; Mourad Z; Naji S; Hentati F
    Neuropediatrics; 2008 Jun; 39(3):176-8. PubMed ID: 18991198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wilson's disease: demonstration of lesions of the cortex and white matter by MRI].
    Le Fort D; Deleplanque B; Louiset P; Pautrizel B; Loiseau P
    Rev Neurol (Paris); 1988; 144(5):365-7. PubMed ID: 3420353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late presentation of Wilson's disease].
    Santander Vaquero C
    Rev Esp Enferm Dig; 2002 Aug; 94(8):502-3. PubMed ID: 12486857
    [No Abstract]   [Full Text] [Related]  

  • 5. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current principles of Wilson's disease--diagnosis and treatment].
    Najda J; Stella-Hołowiecka B; Machalski M; Woszczyk D; Mykała-Cieśla J
    Wiad Lek; 2002; 55(9-10):600-7. PubMed ID: 12607416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration].
    Grau-Veciana JM; Barraquer-Bordas L
    Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotypies in Wilson's disease.
    Yorio AA; Mesri JC; Pagano MA; Lera G
    Mov Disord; 1997 Jul; 12(4):614-6. PubMed ID: 9251089
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic thrombocytopenia associated with Wilson's disease.
    Donfrid M; Jankovic G; Strahinja R; Colovic R; Begic-Janeva A; Colovic M
    Hepatogastroenterology; 1998; 45(23):1774-6. PubMed ID: 9840146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
    Alexiou D; Hatzis T; Koutselinis A
    Arch Fr Pediatr; 1985; 42(6):447-9. PubMed ID: 4051676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cranial MR imaging in Wilson's disease.
    King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
    AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chelation treatment of neurological Wilson's disease.
    Walshe JM; Yealland M
    Q J Med; 1993 Mar; 86(3):197-204. PubMed ID: 8369040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
    Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
    Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
    Boudin G; Pépin B; Milhaud M; Jérome H; Pacilly A
    Rev Neurol (Paris); 1968 Jan; 118(1):27-35. PubMed ID: 5697565
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible magnetic resonance imaging lesions in Wilson's disease: clinical-anatomical correlation.
    Takahashi W; Yoshii F; Shinohara Y
    J Neuroimaging; 1996 Oct; 6(4):246-8. PubMed ID: 8903079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilson's disease: modification by L-DOPA.
    Gelmers HJ; Troost J; Willemse J
    Neuropadiatrie; 1973 Dec; 4(4):453-7. PubMed ID: 4801897
    [No Abstract]   [Full Text] [Related]  

  • 18. [EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
    Lang HD; Reichenmiller HE; Tigges FJ; Braun HJ; Golisch G
    Med Klin; 1972 Jun; 67(26):916-21. PubMed ID: 5048687
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M; Percl M; Jadresin O; Kolacek S
    Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Wilson's disease].
    Pépin B; Barraine R
    Cah Coll Med Hop Paris; 1968 Feb; 9(2):184-7. PubMed ID: 5745277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.